Trial intelligence / Profile preview

High-Dose vs Conventional Escitalopram in OCD

NCT00723060Phase 4Completed

Sponsor
Seoul National University Hospital
Start
Sep 2008
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of escitalopram in obsessive compulsive disorder (OCD), sponsored by Seoul National University Hospital. Started Sep 2008; status: completed.

02

Drugs

escitalopram
03

Conditions

obsessive compulsive disorder (OCD)

Beyond the preview

Go deeper on NCT00723060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00723060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call